Search results for "dopamine"

showing 10 items of 660 documents

Involvement of 5-hydroxytryptamine 5-HT3 serotonergic receptors in the acquisition and reinstatement of the conditioned place preference induced by M…

2013

Some MDMA (3,4-methylenedioxymethamphetamine) users develop dependence as a result of chronic consumption. The present study evaluated the role of 5-hydroxytryptamine 5-HT₃ receptors in the acquisition, expression and reinstatement of the conditioned place preference (CPP) induced by MDMA. Adolescent male mice were conditioned with 10 mg/kg of MDMA and then treated with 1 or 3mg/kg of the 5-hydroxytryptamine 5-HT₃ antagonist MDL72222 during acquisition of conditioning (experiment 1), before expression of CPP in a post-conditioning test (experiment 2) or before a reinstatement test (experiment 3). MDL72222 was devoid of motivational effects but blocked acquisition of the MDMA-induced CPP. Mo…

PharmacologyAntagonistMDMAExtinction (psychology)StriatumPharmacologySerotonergicConditioned place preferencenervous systemDopaminemental disordersmedicineSerotoninPsychologypsychological phenomena and processesmedicine.drugEuropean Journal of Pharmacology
researchProduct

1-(2′-Bromobenzyl)-6,7-dihydroxy-N-methyl-tetrahydroisoquinoline and 1,2-Demethyl-nuciferine as Agonists in Human D2 Dopamine Receptors

2020

Certain D2-like dopamine receptor (DR) agonists are useful therapeutically as antiparkinsonian drugs, whereas D2-like DR antagonists or partial agonists are proven effective as antipsychotics. Two ...

PharmacologyD2 dopamine receptorsAntiparkinsonian drugsNuciferine010405 organic chemistryTetrahydroisoquinolineOrganic ChemistryPharmaceutical SciencePharmacology01 natural sciencesPartial agonist0104 chemical sciencesAnalytical Chemistry010404 medicinal & biomolecular chemistrychemistry.chemical_compoundComplementary and alternative medicinechemistryDopamine receptorDrug DiscoveryMolecular MedicineJournal of Natural Products
researchProduct

Nigral control of hippocampal epilepsy: a dopaminergic hypothesis

1988

PharmacologyEpilepsybusiness.industryDopamineDopaminergicHippocampusSubstantia nigraHippocampal formationmedicine.diseaseHippocampusBasal GangliaElectric StimulationSubstantia NigraKineticsEpilepsyDopamineBasal gangliaCatsHaloperidolmedicineAnimalsHaloperidolbusinessNeurosciencemedicine.drugPharmacological Research Communications
researchProduct

Adolescent pre-exposure to ethanol and 3,4-methylenedioxymethylamphetamine (MDMA) increases conditioned rewarding effects of MDMA and drug-induced re…

2011

Many adolescents often take ethanol (EtOH) in combination with 3,4-methylenedioxymethylamphetamine (MDMA). In the present work, we used a mouse model to study the effect of repeated pre-exposure during adolescence to EtOH (2 g/kg), MDMA (10 or 20 mg/kg) or EtOH + MDMA on the rewarding and reinstating effects of MDMA in the conditioned place preference (CPP) paradigm. Pre-exposure to EtOH, MDMA or both increased the rewarding effects of a low dose of MDMA (1.25 mg/kg). These pre-treatments did not affect the acquisition of the CPP induced by 5 mg/kg of MDMA. However, the CPP was more persistent in mice pre-exposed to both doses of MDMA or to EtOH + MDMA20. After extinction of the CPP induced…

PharmacologyEthanolHomovanillic acidMedicine (miscellaneous)MDMAExtinction (psychology)StriatumPharmacologyConditioned place preferencePsychiatry and Mental healthchemistry.chemical_compoundchemistryDopaminemental disordersmedicineSerotoninpsychological phenomena and processesmedicine.drugAddiction Biology
researchProduct

The dopamine D3 antagonist U-99194A maleate increases social behaviors of isolation-induced aggressive male mice.

1999

Rationale: Blockade of D1/D2 dopamine receptors produce an antiaggressive action commonly associated with an impairment of other motor behaviors. The D3 receptor seems to present opposite actions to the D1 and D2, since the blockade of this receptor produces stimulation of motor activity which has been associated with an increase in dopamine neurotransmission. Objective: In this work, the action of the dopamine D3 antagonist U-99194a maleate on locomotor activity and in a social interaction test in male mice was evaluated. Methods: Animals isolated during 30 days were treated with U-99194a maleate (20–40 mg/kg) or saline and locomotor activity was measured 20 min after drug administration. …

PharmacologyMaleAnalysis of VarianceBehavior AnimalAntagonistBiological activityStimulationPharmacologyBlockadeDevelopmental psychologyAggressionMiceDopamine receptor D3IndansAnimalsDopamine AntagonistsAnalysis of varianceReceptorPsychologySocial behaviorPsychopharmacology
researchProduct

Head-twitch and forepaw-shake responses after single and repeated treatment with rolipram: interaction with noradrenergic and dopaminergic agonists a…

1988

PharmacologyMaleBehavior AnimalChemistryDopamine AgentsRats Inbred StrainsShakePharmacologyAutonomic AgentsPyrrolidinonesRatsRepeated treatmentForelimbmedicineHead (vessel)AnimalsDopamine AntagonistsDrug InteractionsDopaminergic AgonistsHeadRolipramRoliprammedicine.drugPharmacological research communications
researchProduct

The action of iontophoretically applied acetylcholine and dopamine on single claustrum neurones in the cat.

1981

Abstract The effects of iontophoretically applied acetyl-choline (ACh) and dopamine (DA) on spontaneously active claustral neurones, in chloralose-anaesthetised cats, have been investigated. Acetylcholine had both facilitatory and inhibitory effects in almost the same proportions. The action of DA was prevalently inhibitory. Two types of inhibitory response to ACh and DA are described: short-lasting inhibition and long-lasting inhibition. The excitatory response always outlasted the period of drug application.

PharmacologyNeuronsCATSChemistryDopamineNeural InhibitionDrug applicationIontophoresisInhibitory postsynaptic potentialClaustrumAcetylcholineBasal GangliaCellular and Molecular NeuroscienceDopamineExcitatory postsynaptic potentialmedicineCatsAnimalsNeuroscienceAcetylcholinemedicine.drugNeuropharmacology
researchProduct

Therapeutic monitoring of new antipsychotic drugs.

2004

Typical antipsychotic drugs qualify for therapeutic drug monitoring (TDM) primarily for the following reasons: control of compliance and avoidance of extrapyramidal side effects by keeping chronic exposure to minimal effective blood levels. For the atypical antipsychotic clozapine, drug safety is another reason to use TDM. With regard to the new antipsychotics risperidone, olanzapine, quetiapine, amisulpride, ziprasidone, and aripiprazole, which have been introduced in the clinic during the last few years, the rationale to use TDM is a matter of debate. Positron emission tomography (PET), which enables measurement of the occupancy of dopamine D2 receptors, revealed that receptor occupancy c…

PharmacologyOlanzapinemedicine.diagnostic_testDose-Response Relationship Drugmedicine.drug_classbusiness.industryReceptors Dopamine D2medicine.medical_treatmentAtypical antipsychoticPharmacologyTypical antipsychoticStructure-Activity RelationshipTherapeutic drug monitoringmedicineQuetiapineHumansPharmacology (medical)ZiprasidoneAmisulprideDrug MonitoringAntipsychoticbusinessmedicine.drugAntipsychotic AgentsTherapeutic drug monitoring
researchProduct

Editorial [ Neurodegenerative Disorders: From Molecules to Man (Part 2) Guest Editors: Giuseppe Di Giovanni, Vincenzo Di Matteo and Ennio Esposito ]

2008

NEURODEGENERATIVE DISORDERS: FROM MOLECULES TO MAN

PharmacologyPARKINSON'S DOPAMINEbusiness.industryGeneral NeuroscienceMEDLINEMedicinebusinessBioinformaticsSettore BIO/09 - FisiologiaIntroductory Journal ArticleCNS & Neurological Disorders - Drug Targets
researchProduct

Critical role of Nitric Oxide on Nicotine-Induced Hyperactivation of Dopaminergic Nigrostriatal System: Electrophysiological and Neurochemical eviden…

2010

Nicotine, the main psychoactive ingredient in tobacco, stimulates dopamine (DA) function, increasing DA neuronal activity and DA release. DA is involved in both motor control and in the rewarding and reinforcing effects of nicotine; however, the complete understanding of its molecular mechanisms is yet to be attained. Substantial evidence indicates that the reinforcing properties of drugs of abuse, including nicotine, can be affected by the nitric oxide (NO) system, which may act by modulating central dopaminergic function. In this study, using single cell recordings in vivo coupled with microiontophoresis and microdialysis in freely moving animals, the role of NO signaling on the hyperacti…

PharmacologyPars compactaChemistryDopaminergicSubstantia nigraStriatumPharmacologyNicotinePsychiatry and Mental healthNeurochemicalnervous systemDopaminePhysiology (medical)medicinePremovement neuronal activityPharmacology (medical)medicine.drugCNS Neuroscience & Therapeutics
researchProduct